Medical experts warn against unsupervised GLP-1 weight loss injections

Medical experts are warning against the unsupervised use of GLP-1 group medications, commonly known as weight loss injections, for obesity treatment. While these drugs can support weight loss in appropriate patients, doctors emphasize that they are powerful medical agents affecting metabolism, hormones, and blood sugar, rather than simple supplements.

Specialists note that using these medications based on social media advice or peer recommendations can lead to serious health complications. Potential risks include adverse effects on the pancreas, gallbladder, and digestive system. Specific groups, such as those with a history of pancreatitis, gallbladder disease, or medullary thyroid cancer risk, may face significant dangers.

Effective treatment requires professional medical supervision, including baseline testing for blood sugar, insulin resistance, cholesterol, and organ function. Experts highlight that long-term success depends on lifestyle changes, including diet and physical activity, noting that without these changes, there is a high probability of regaining weight after discontinuing the medication.